Printer Friendly

AMEX'S BIOTECHNOLOGY INDEX VALUE NOW AVAILABLE ON MARKET DATA MACHINES

AMEX'S BIOTECHNOLOGY INDEX VALUE NOW AVAILABLE ON MARKET DATA MACHINES
 NEW YORK, March 24 /PRNewswire/ -- The American Stock Exchange today began disseminating the value of its newly developed Biotechnology Index through the Consolidated Tape Authority's Network-B. The new information is now available on market data machines under ticker symbol "BTK."
 In January of this year, the Amex filed with the Securities and Exchange Commission (SEC) for permission to trade options on its Biotechnology Index, which is based on 15 leading biotechnology stocks. Each stock in the Index was chosen for its representation of the industry, trading liquidity and market value.
 In its index design, the Exchange has utilized a unique equal-dollar weighting calculation method that will provide each stock in the Index with a
more balanced representation than currently popular index methods. This method is particularly important in rapidly developing industries such biotechnology, where new discoveries or developments can sharply increase a company's stock price and market value in a very short time.
 The new Index will be updated and disseminated every 15 seconds over market data machines. The Amex's Biotechnology Index comprises the following stocks:
 Amgen, Inc. Centocor, Inc.
 Chiron Corp. Biogen, Inc.
 Cytogen Corp. Scios Inc.
 Genzyme Corp. Immunex Corp.
 Mycogen Corp. Immune Response Corp.
 ImmunoGen, Inc. Mycogen Corp.
 Gensia Pharmaceuticals MedImmune, Inc.
 Xoma Corp.
 The Exchange expects to introduce options trading on the Biotechnology Index shortly after SEC approval is obtained.
 The Amex trades a total of 276 stock options, including 81 options on over-the-counter stocks. In addition, options are traded on five broad market indexes -- the Major Market Index (XMI), XMI LEAPS(TM) (XLT), S&P MidCap 400 Index (MID), the Institutional Index (XII) and the Japan Index (JPN) -- as well as two industry-based indexes --the Oil Index (XOI) and the Computer Technology Index (XCI). CAPS -- capped options -- are traded on XMI and XII as well. The Exchange also trades 29 LEAPS (TM) on leading stocks which have expirations up to almost three years.
 -0- 3/24/92
 /CONTACT: Shelly Wolfe of AMEX, 212-306-1641/ CO: American Stock Exchange ST: New York IN: FIN SU: SM -- NY040 -- 1099 03/24/92 13:05 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 24, 1992
Words:357
Previous Article:PRESBYTERIAN AND ORTHOPAEDIC HOSPITALS ANNOUNCE AGREEMENT
Next Article:NORFOLK SOUTHERN COMPLETES PLANTING OF 42,000 TREES AT ISLE OF WIGHT COUNTY, VIRGINIA PLANNED COAL GROUND STORAGE FACILITY
Topics:


Related Articles
AMEX DEVELOPS BIOTECHNOLOGY INDEX; SEEKS SEC PERMISSION TO TRADE OPTIONS ON NEW INDEX
CBOE TO TRADE OPTIONS ON BIOTECH INDEX
AMEX TO LAUNCH OPTIONS TRADING ON THE BIOTECHNOLOGY INDEX ("BTK") OCT. 9
CBOE SETS OCT. 9 LAUNCH FOR CBOE BIOTECH INDEX OPTIONS, LEAPS (R)
AMEX KICKS OFF OPTIONS TRADING ON ITS BIOTECHNOLOGY INDEX ("BTK")
AMEX LAUNCHES OPTIONS TRADING ON GROUPING OF TOP EUROPEAN STOCKS, EUROTOP 100 INDEX; EXCHANGE SCHEDULES EARLY MORNING TRADING SESSION
AMEX PRESCRIBES NEW STOCK ALIGNMENT FOR ITS BIOTECHNOLOGY INDEX; REPLACES IMMUNEX CORPORATION WITH IMMUNE RESPONSE CORPORATION
NEW SECURITIES BROKER/DEALER INDEX TO BE OFFERED ON THE AMEX; OPTIONS TRADING TO BEGIN MAY 12
American Stock Exchange Lists Common Stock of Interleukin Genetics Incorporated.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters